Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Enrique Sanz-García"'
Autor:
Elena Elez, Chiara Chianese, Enrique Sanz‐García, Erica Martinelli, Alba Noguerido, Francesco Mattia Mancuso, Ginevra Caratù, Judit Matito, Julieta Grasselli, Claudia Cardone, Riziero Esposito Abate, Giulia Martini, Cristina Santos, Teresa Macarulla, Guillem Argilés, Jaume Capdevila, Ariadna Garcia, Nuria Mulet, Evaristo Maiello, Nicola Normanno, Frederick Jones, Josep Tabernero, Fortunato Ciardello, Ramon Salazar, Ana Vivancos
Publikováno v:
Molecular Oncology, Vol 13, Iss 9, Pp 1827-1835 (2019)
Despite major advances in the treatment of metastatic colorectal cancer (mCRC), the survival rate remains very poor. This study aims at exploring the prognostic value of RAS‐mutant allele fraction (MAF) in plasma in mCRC. Forty‐seven plasma sampl
Externí odkaz:
https://doaj.org/article/3ba50329631d4c038cfdd0a1c4537257
Autor:
Federico Longo-Muñoz, Daniel Castellano, Jerome Alexandre, Sant P. Chawla, Cristian Fernández, Carmen Kahatt, Vicente Alfaro, Mariano Siguero, Ali Zeaiter, Victor Moreno, Enrique Sanz-García, Ahmad Awada, Ana Santaballa, Vivek Subbiah
Publikováno v:
Scientia
European journal of cancer (Oxford, England : 1990)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
European journal of cancer (Oxford, England : 1990)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Lurbinectedin; Neuroendocrine tumours; Small cell Lurbinectedina; Tumores neuroendocrinos; Célula pequeña Lurbinectedina; Tumors neuroendocrins; Cèl·lula petita Background Patients with neuroendocrine tumours (NETs) need alternative therapies aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1d605cd1021c2a275ca1c4d159c945
https://hdl.handle.net/11351/8198
https://hdl.handle.net/11351/8198
Autor:
Wei Xu, Anna Spreafico, Stephanie Lheureux, Marcus O Butler, Aaron R Hansen, Eric Chen, Ben Wang, Philippe L Bedard, Albiruni Abdul Razak, Dave Cescon, Lillian L Siu, Tak W Mak, Geoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, Zhihui Amy Liu, SY Cindy Yang, Shaofeng Liu, Shawn Kubli, Hal Berman, Thomas Pfister, Sofia Genta
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/ac4b2939869148ab89ef75e7870dcc1b
Autor:
Enrique, Sanz-García, Elez, Elena, Caratu, Ginevra, Matito, Judit, Garcia, Ariadna, Grasselli, Julieta, Martínez-Villacampa, Mercedes, Santos, Cristina, Mulet, Nuria, Vidal, Joana, Argiles, Guillem, Macarulla, Teresa, Capdevila, Jaume, Sauri, Tamara, Matos, Ignacio, Aranda, Enrique, Jones, Frederick, Dientsmann, Rodrigo, Montagut, Clara, Tabernero, Josep, Salazar, Ramon, Vivancos, Ana
Publikováno v:
In Annals of Oncology June 2017 28 Supplement 3:iii140-iii140
Autor:
Elena Élez, Núria Mulet-Margalef, Miriam Sanso, Fiorella Ruiz-Pace, Francesco M. Mancuso, Raquel Comas, Javier Ros, Guillem Argilés, Giulia Martini, Enrique Sanz-Garcia, Iosune Baraibar, Francesc Salvà, Alba Noguerido, Jose Luis Cuadra-Urteaga, Roberta Fasani, Ariadna Garcia, Jose Jimenez, Susana Aguilar, Stefania Landolfi, Javier Hernández-Losa, Irene Braña, Paolo Nuciforo, Rodrigo Dienstmann, Josep Tabernero, Ramon Salazar, Ana Vivancos
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 118 (2022)
The search for immunotherapy biomarkers in Microsatellite Instability High/Deficient Mismatch Repair system (MSI-H/dMMR) metastatic colorectal cancer (mCRC) is an unmet need. Sixteen patients with mCRC and MSI-H/dMMR (determined by either immunohisto
Externí odkaz:
https://doaj.org/article/f77ab85a817d47428099bae4d6a1c90a
Autor:
Rodrigo Dienstmann, Elena Elez, Guillem Argiles, Ignacio Matos, Enrique Sanz‐Garcia, Carolina Ortiz, Teresa Macarulla, Jaume Capdevila, Maria Alsina, Tamara Sauri, Helena Verdaguer, Marta Vilaro, Fiorella Ruiz‐Pace, Cristina Viaplana, Ariadna Garcia, Stefania Landolfi, Hector G. Palmer, Paolo Nuciforo, Jordi Rodon, Ana Vivancos, Josep Tabernero
Publikováno v:
Molecular Oncology, Vol 11, Iss 9, Pp 1263-1272 (2017)
Sequencing of tumors is now routine and guides personalized cancer therapy. Mutant allele fractions (MAFs, or the ‘mutation dose’) of a driver gene may reveal the genomic structure of tumors and influence response to targeted therapies. We perfor
Externí odkaz:
https://doaj.org/article/db9cadd2428d4ebebd17baf85c373983